Scarica l'app Stockscreener
4.91
0.41%
0.02
Dopo l'orario di chiusura:
4.91
Precedente Chiudi:
$4.89
Aprire:
$4.99
Volume 24 ore:
592.50K
Relative Volume:
0.54
Capitalizzazione di mercato:
$622.87M
Reddito:
$433.14M
Utile/perdita netta:
$4.95M
Rapporto P/E:
137.54
EPS:
0.0357
Flusso di cassa netto:
$6.55M
1 W Prestazione:
+9.11%
1M Prestazione:
+14.19%
6M Prestazione:
+33.42%
1 anno Prestazione:
+84.59%
Intervallo 1D:
$4.82
$4.995
Intervallo di 1 settimana:
$3.58
$4.995
Portata 52W:
$2.45
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Nome
Organogenesis Holdings Inc
Settore
Telefono
781-575-0775
Indirizzo
85 DAN ROAD, CANTON, MA
Confronta ORGO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.91 | 585.45M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Lake Street | Buy |
| 2024-02-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Iniziato | SVB Leerink | Outperform |
| 2019-08-26 | Ripresa | Credit Suisse | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
| 2019-04-17 | Iniziato | Oppenheimer | Outperform |
| 2019-04-11 | Iniziato | SunTrust | Buy |
Mostra tutto
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
Published on: 2025-08-13 08:16:18 - Newser
Analyzing recovery setups for Organogenesis Holdings Inc. investorsPortfolio Return Summary & Capital Protection Trade Alerts - Newser
August 2025's Top Growth Stocks With Strong Insider Confidence - simplywall.st
What technical models suggest about Organogenesis Holdings Inc.’s comebackWeekly Investment Report & Verified Momentum Watchlists - Newser
What analysts say about Organogenesis Holdings Inc. stock outlookEarnings Summary Report & Daily Stock Momentum Reports - Newser
Market reaction to Organogenesis Holdings Inc.’s recent newsEarnings Growth Report & Safe Capital Growth Tips - Newser
Is Organogenesis Holdings Inc. stock entering bullish territoryFree Entry Alert Based on Volume Spikes - Newser
Will Organogenesis Holdings Inc. outperform during market ralliesTop High Return Intraday Stocks - thegnnews.com
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2025 Earnings Call Transcript - Insider Monkey
What makes Organogenesis Holdings Inc. stock price move sharplyAI Swing Strategy Signal Forecasting System - Newser
Cantor Fitzgerald maintains Overweight rating on Organogenesis stock By Investing.com - Investing.com Nigeria
Is Organogenesis Holdings Inc. reversing from oversold territoryFree Weekly Chart Analysis With Entry Advice - Newser
Applying Elliott Wave Theory to Organogenesis Holdings Inc.Loss Limitation Strategy Based on Analysis - Newser
How to track smart money flows in Organogenesis Holdings Inc.Free Entry and Exit Strategy Optimizer Tool - Newser
Detecting support and resistance levels for Organogenesis Holdings Inc.Free Fast Entry High Potential Stock Alerts - Newser
Organogenesis Holdings Inc. shares fall 6.64% intraday after reporting second quarter earnings. - AInvest
Transcript : Organogenesis Holdings Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Organogenesis stock price target raised to $9 by Cantor Fitzgerald - Investing.com Canada
Earnings call transcript: Organogenesis Q2 2025 misses EPS forecast, stock steady - Investing.com
Earnings call transcript: Organogenesis Q2 2025 misses EPS forecast, stock steady By Investing.com - Investing.com South Africa
Organogenesis: Q2 Earnings Snapshot - Connecticut Post
Organogenesis Holdings Inc (ORGO) Q2 2025 Earnings Call Highlights: Navigating Market Uncertainties Amidst Strong Growth in Surgical and Sports Medicine Products. - AInvest
Organogenesis Holdings Reports Mixed Q2 2025 Results - TipRanks
Organogenesis Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Organogenesis Amends Credit Agreement Amid Revenue Decline - TipRanks
Can you recover from losses in Organogenesis Holdings Inc.Free Alert Feed for Momentum Based Picks - Newser
Intraday pattern recognizer results for Organogenesis Holdings Inc.Entry Optimization Guide with Volume Analysis - Newser
Will a bounce in Organogenesis Holdings Inc. offer an exitWatchlist Generator for Smart Money Signals - Newser
Organogenesis Holdings (NASDAQ:ORGO) Shareholders Are Still up 82% Over 1 Year Despite Pulling Back 10% in the Past Week - 富途牛牛
Analyzing drawdowns of Organogenesis Holdings Inc. with statistical toolsReal-Time Investment Signal Forecast with AI - Newser
Momentum divergence signals in Organogenesis Holdings Inc. chartFree Long Hold Safe Return Strategy - Newser
Moving Average Trends for Organogenesis Holdings Inc. Stock: What They IndicateSummary of Trade Cycles in 5-Year Range - Newser
How many analysts rate Organogenesis Holdings Inc. as a “Buy”Capitalize on market momentum for maximum profit - Jammu Links News
Is Organogenesis Holdings Inc. a growth stock or a value stockInvest smarter with cutting-edge analytics - Jammu Links News
What is Organogenesis Holdings Inc. company’s growth strategyMaximize gains with data-driven stock picks - Jammu Links News
What are analysts’ price targets for Organogenesis Holdings Inc. in the next 12 monthsConsistently superior profits - Jammu Links News
Is Organogenesis Holdings Inc. stock overvalued or undervaluedDiscover stocks with explosive upside potential - Jammu Links News
What catalysts could drive Organogenesis Holdings Inc. stock higher in 2025Exceptional risk-adjusted gains - Jammu Links News
How does Organogenesis Holdings Inc. compare to its industry peersBuild a diversified portfolio for steady growth - Jammu Links News
What institutional investors are buying Organogenesis Holdings Inc. stockOutstanding growth strategies - Jammu Links News
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Organogenesis Holdings Inc Azioni (ORGO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):